Investors

Investor Highlights

1. highlight 1

  • bullet
  • bullet
  • bullet

2. highlight 2

  • bullet
  • bullet
  • bullet

3. highlight 2

  • bullet
  • bullet
  • bullet

Annual General Meeting

InsuLife will hold General Meetings to guarantee a shareholder’s participation in the company’s highest body. An Annual General Meeting shall be held by the 30 of June each year. Notice of the General Meeting shall be sent to all shareholders with a known address.
MEETING MINUTES & PROTOCOLS (PDF) >

Event Calendar

Annual Meeting
2024 Date to be determined

Nordic-American Healthcare Conference 2023
December 6-7, 2023

Presentations

January 2024 Company Presentation

Insulife's presentation highlights its milestones, pilot study successes, supply chain strengths, and patent advancements, encapsulating the company's innovation and growth.
DOWNLOAD PRESENTATION (PDF) >

Investor Relations Contact

Henrik Bruun Andersen
Chief Financial Officer
email address
Subscribe for InsuLife News Updates
Sign up to receive the latest InsuLife news, updates and investing information delivered right to your inbox.
Newsletter Form (#1)
InsuLife is a Norwegian company aiming at bringing the unparalleled developmental INS-2301 skin-applied insulin to market.
Learn More
© Copyright 2024 - InsuLife AS, All Rights Reserved
cross